Pharmact

OUR MISSION

We focus on the most significant disease, where our new drug shows the effectiveness in the application of our therapy. Our goal is to improve your health.
.

More...

Pharmact

INTERNATIONAL

We work worldwide with pharmaceutical whole-seller and distributions. We are pleased if you would like being part of our network.
.
.

More...

Pharmact

NEW INGREDIENT

The development of the recombinant enzyme is patent-protected. It is used in the therapy of patients with arteriosclerosis and other diseases.
.

More...

NEWS PRODUCTS

Screening for metabolic diseases on early stages

The effective therapy of diabetes mellitus and arteriosclerosis as well as their sequelae is one of the greatest medical challenges of our time. More…

NEW PROJECTS

New drug in process

Arteriosclerosis is a silent disease, which partly leads to calcifying with stiffening of vessel tissue. Pharmact has developed an optimal active drug by genetic engineering. The substance is has been brought in progress for the approval process as a pharmaceutical.

Interested in more?
Ask our partners!

DISTRIBUTION

EUROPE

Pharmact GmbH
Int´l Distribution
Headquarters
Phone: +49 621-1806178-0
E-Mail: sales@pharmact.de

USA

Pharmact Healthcare Inc.
Distribution
USA / CAN
Phone: +1 813 200 5884
E-Mail:
sales@pharmact.us